ORCA-3 Phase 3 Trial Reports Statistically Significant Topline Efficacy Results in Smoking Cessation
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
05/16/23 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
20 |
04/28/23 | ARS | Annual report to security holders |
![]() |
104 | |
03/16/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
170 |
03/10/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
108 |
03/11/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
102 |
03/13/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
111 |
03/14/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
145 |
03/01/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
177 |
02/23/17 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
117 |
03/09/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
103 |